Table 1.
Neurodegenerative diseases | Rheumatoid arthritis | Cancer | Cardiovascular diseases | Metabolic diseases | References | |
---|---|---|---|---|---|---|
Innate immunity | ||||||
Inflammaging | ✓ | ✓ | ✓ | ✓ | ✓ | [8, 25, 57, 66, 79, 99] |
Expansion of M1 macrophages | ✓ | ✓ | ✓ | ✓ | ✓ | [24, 57, 79, 94, 100, 101] |
Expansion of CD14++CD16+ monocytes | ✓ | ✓ | ✓ | ✓ | [73, 102–104] | |
Expansion of myeloid-derived suppressor cells | ✓ | ✓ | ✓ | [105, 106] | ||
Adaptive immunity | ||||||
Decreased thymic function | ✓ | [107] | ||||
Contraction of T cell repertoire | ✓ | [108] | ||||
Expansion in late-differentiated CD28− T cells | ✓ | ✓ | ✓ | ✓ | ✓ | [15, 28, 29, 52, 82] |
Expansion of TEMRA cells | ✓ | ✓ | [17, 31] | |||
Expansion of regulatory T cells (FoxP3+) | ✓ | ✓ | [54, 109] | |||
Increased CMV serology | ✓ | ✓ | ✓ | ✓ | [52, 110–113] | |
Increased plasma autoantibodies | ✓ | ✓ | ✓ | [44, 114–116] |
Abbreviations: CMV, cytomegalovirus; FoxP3, forkhead box P3; TEMRA, effector memory T cells re-expressing CD45RA